Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,208 | 163 | 95.4% |
| Education | $154.94 | 2 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $529.59 | 26 | $0 (2024) |
| Janssen Biotech, Inc. | $454.92 | 28 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $403.32 | 20 | $0 (2024) |
| Lilly USA, LLC | $294.68 | 17 | $0 (2024) |
| GENZYME CORPORATION | $249.31 | 8 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $232.37 | 9 | $0 (2024) |
| LEO Pharma Inc. | $224.26 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $204.68 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $145.43 | 5 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $134.17 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,931 | 98 | ABBVIE INC. ($343.24) |
| 2023 | $845.06 | 42 | Janssen Biotech, Inc. ($235.90) |
| 2022 | $442.99 | 22 | ABBVIE INC. ($135.41) |
| 2020 | $143.71 | 3 | Genentech USA, Inc. ($122.03) |
All Payment Transactions
165 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: Immunology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.89 | General |
| Category: Immunology | ||||||
| 12/09/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: Immunology | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.62 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.17 | General |
| Category: Immunology | ||||||
| 12/03/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: DERMATOLOGY | ||||||
| 11/12/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: DERMATOLOGY | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.06 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.44 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.73 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $29.18 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: Immunology | ||||||
| 10/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,639 | 3,056 | $383,793 | $116,233 |
| 2022 | 13 | 1,557 | 3,099 | $360,873 | $124,799 |
| 2021 | 20 | 2,324 | 19,314 | $630,037 | $212,368 |
| 2020 | 21 | 2,081 | 10,356 | $491,861 | $156,291 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 451 | 612 | $114,958 | $34,426 | 29.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 211 | 238 | $51,003 | $15,945 | 31.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 100 | 125 | $43,821 | $14,689 | 33.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 122 | 135 | $31,803 | $10,754 | 33.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 249 | 301 | $47,901 | $10,478 | 21.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 202 | 1,274 | $18,881 | $6,220 | 32.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 74 | 74 | $17,149 | $4,666 | 27.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 76 | 116 | $13,002 | $4,620 | 35.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 60 | $15,990 | $4,570 | 28.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 15 | 15 | $5,556 | $2,097 | 37.7% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 21 | 22 | $6,758 | $1,992 | 29.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,542 | $1,844 | 33.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 35 | 40 | $4,609 | $1,673 | 36.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 13 | 15 | $4,036 | $1,520 | 37.7% |
| 69100 | Biopsy of ear | Office | 2023 | 12 | 13 | $2,782 | $741.31 | 26.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 430 | 595 | $111,765 | $40,558 | 36.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 83 | 113 | $39,614 | $15,422 | 38.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 182 | 211 | $45,217 | $15,266 | 33.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 138 | 165 | $38,871 | $14,096 | 36.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 261 | 319 | $50,766 | $13,134 | 25.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 213 | 1,381 | $20,466 | $7,445 | 36.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 65 | 119 | $13,339 | $4,969 | 37.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 63 | 63 | $14,600 | $4,901 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 54 | $14,391 | $4,842 | 33.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 16 | 16 | $4,305 | $1,683 | 39.1% |
About Dr. Elizabeth Cassinelli, M.D
Dr. Elizabeth Cassinelli, M.D is a Dermatology healthcare provider based in Reno, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2015. The National Provider Identifier (NPI) number assigned to this provider is 1710372743.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elizabeth Cassinelli, M.D has received a total of $3,363 in payments from pharmaceutical and medical device companies, with $1,931 received in 2024. These payments were reported across 165 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,208).
As a Medicare-enrolled provider, Cassinelli has provided services to 7,601 Medicare beneficiaries, totaling 35,825 services with total Medicare billing of $609,691. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Reno, NV
- Active Since 04/06/2015
- Last Updated 01/31/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1710372743
Products in Payments
- TREMFYA (Drug) $454.92
- DUPIXENT (Biological) $449.95
- SKYRIZI (Biological) $362.89
- TALTZ (Drug) $294.68
- ADBRY (Biological) $224.26
- Winlevi (Drug) $211.60
- ILUMYA (Biological) $191.72
- Sotyktu (Drug) $159.86
- RINVOQ (Biological) $144.19
- VTAMA (Drug) $131.07
- Erivedge (Biological) $122.03
- COSENTYX (Drug) $81.83
- JUBLIA (Drug) $80.87
- Zoryve (Drug) $74.63
- EUCRISA (Drug) $58.27
- Otezla (Drug) $40.95
- LIBTAYO (Biological) $31.73
- HUMIRA (Biological) $22.51
- Cimzia (Drug) $20.00
- AKLIEF (Drug) $16.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Reno
Laura Ostezan, M.d, M.D
Dermatology — Payments: $27,692
Laura Biehle, Pa-C, PA-C
Dermatology — Payments: $25,736
Dr. William Mortensen, M.d, M.D
Dermatology — Payments: $12,827
Mrs. Diane Smith, Aprn, APRN
Dermatology — Payments: $11,999
Mrs. Cindy Lamerson, Md, MD
Dermatology — Payments: $8,873
Dr. Gretchen Korver, M.d, M.D
Dermatology — Payments: $8,444